| 451 |
12: AchE Inhibition |
39: Increased Cholinergic Signaling |
Nov 29, 2016 |
Dec 20, 2019 |
2 AOPs
|
| 452 |
12: AchE Inhibition |
351: Increased Mortality |
Nov 29, 2016 |
Dec 20, 2019 |
1 AOP
|
| 453 |
12: AchE Inhibition |
442: Decreased, Population trajectory |
Nov 29, 2016 |
Dec 20, 2019 |
None
|
| 2007 |
12: AchE Inhibition |
1703: Cardiovascular dysregulation |
Nov 25, 2019 |
Dec 20, 2019 |
1 AOP
|
| 2014 |
12: AchE Inhibition |
1705: Impaired coordination and movement |
Dec 20, 2019 |
Dec 20, 2019 |
1 AOP
|
| 2016 |
12: AchE Inhibition |
360: Decrease, Population growth rate |
Dec 20, 2019 |
Dec 20, 2019 |
1 AOP
|
| 2653 |
12: AchE Inhibition |
1391: Activation of Cyp2E1 |
May 16, 2022 |
May 16, 2022 |
1 AOP
|
| 3063 |
12: AchE Inhibition |
2195: Increase, CNS Neural cell death |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 3064 |
12: AchE Inhibition |
1944: Dysfunctional synapses |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 3430 |
12: AchE Inhibition |
1602: Activation, Muscarinic Acetylcholine Receptors |
Nov 22, 2024 |
Nov 22, 2024 |
1 AOP
|
| 2032 |
1724: Acinar cell proliferation |
1725: Acinar cell tumors |
Jan 8, 2020 |
Jan 8, 2020 |
1 AOP
|
| 1442 |
1340: Activate, calmodulin |
1341: Increase, myosin light chain phosphorylation |
Apr 14, 2017 |
Apr 14, 2017 |
2 AOPs
|
| 1464 |
1359: Activate, GABA-A receptor |
1322: Increased, intracellular chloride (Cl-) |
Apr 14, 2017 |
Apr 14, 2017 |
1 AOP
|
| 1476 |
1379: Activate, leukocyte |
1385: Activated, gastric ulcer formation |
Apr 17, 2017 |
Apr 17, 2017 |
1 AOP
|
| 1475 |
1380: Activate, mucosal defense |
1367: Inhibit, gastric ulcer formation |
Apr 17, 2017 |
Apr 17, 2017 |
1 AOP
|
| 1488 |
1383: Activate, phospholipase |
1382: Decrease, surfactant |
Apr 17, 2017 |
Apr 17, 2017 |
2 AOPs
|
| 1439 |
1337: Activate, PLC |
1338: Increase, inositol triphosphate |
Apr 14, 2017 |
Apr 14, 2017 |
2 AOPs
|
| 1461 |
1360: Activate, presynaptic neuron 2 |
1361: Increase, GABA |
Apr 14, 2017 |
Apr 14, 2017 |
1 AOP
|
| 3015 |
2173: Activated AKT/ERK/PI3K pathway |
2161: Increase, Vascular disrupting effects |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 3024 |
2173: Activated AKT/ERK/PI3K pathway |
1928: increased,Vascular endothelial dysfunction |
Aug 21, 2023 |
Aug 21, 2023 |
1 AOP
|
| 3010 |
2170: Activated ANG/Tie2 pathway |
2161: Increase, Vascular disrupting effects |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 3020 |
2170: Activated ANG/Tie2 pathway |
1928: increased,Vascular endothelial dysfunction |
Aug 21, 2023 |
Aug 21, 2023 |
1 AOP
|
| 3012 |
2171: Activated BMP/TGF-beta pathway |
2161: Increase, Vascular disrupting effects |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 3021 |
2171: Activated BMP/TGF-beta pathway |
1928: increased,Vascular endothelial dysfunction |
Aug 21, 2023 |
Aug 21, 2023 |
1 AOP
|
| 3013 |
2172: Activated Wnt/Frizzled pathway |
2161: Increase, Vascular disrupting effects |
Aug 21, 2023 |
Aug 21, 2023 |
None
|